研究单位：[1]Shanghai Zhongshan Hospital[2]RenJi Hospital[3]First Affiliated Hospital of Zhejiang University[4]Chengdu University of Traditional Chinese Medicine[5]Xuanwu Hospital, Beijing[6]First People's Hospital of Hangzhou[7]Qingdao Hiser Medical Group[8]Second Affiliated Hospital of Soochow University[9]Huashan Hospital
研究目的：
This is a prospective, multicenter, real-world, registry study, which aims to observe the intermediate and long-term efficacy of different endovascular treatments for TASC C&D aortoiliac occlusive disease.
